ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Tiberius Acquisition Corporation

Tiberius Acquisition Corporation (TIBR)

8.32
0.00
(0.00%)
Closed August 01 4:00PM
0.00
0.00
(0.00%)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
8.32
Bid
0.0001
Ask
9.50
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
8.32
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

TIBR Latest News

Appili Therapeutics to Commence Trading on Main Board of the TSX Exchange

Appili Therapeutics Inc. (TSX: APLI; OTCQX: APLIF) (the Company or Appili), a biopharmaceutical company developing anti-infective drug candidates, today announced that its common shares will...

Appili Submits Protocol for a Phase 3 Study Evaluating Favipiravir for the Treatment of Patients with COVID-19 Infections to ...

Company is committed to evaluating use of the broad-spectrum antiviral in the early treatment setting of COVID-19 to shorten the time to clinical recovery in adult patients with mild to moderate...

Appili Therapeutics to Participate in Upcoming Investor Conferences for H.C. Wainwright & Co. and Maxim Group LLC

Appili Therapeutics Inc. (TSXV: APLI; OTCQX: APLIF) (the Company or Appili), a biopharmaceutical company developing anti-infective drug candidates, today announced that its leadership team will...

Appili Therapeutics Reports Financial and Operational Results for First Quarter of Fiscal Year 2021

Appili Therapeutics Inc. (TSXV: APLI; OTCQX: APLIF) (the Company or Appili), a biopharmaceutical company developing anti-infective drug candidates, today announced its financial and operational...

Appili Therapeutics Receives Eligibility for DTC Trading in the U.S.

Appili Therapeutics Inc. (TSXV: APLI; OTCQX: APLIF) (the Company or Appili), a biopharmaceutical company developing anti-infective drug candidates, today announced that its common shares listed...

FDA Clears Appili Therapeutics to Expand its Phase 2 Clinical Trial of Favipiravir for the Potential Prevention of COVID-19 a...

U.S. expansion of antiviral outbreak control trial in long-term care facilities Favipiravir already approved in India and Russia for emergency use against COVID-19 and as a pandemic influenza...

Appili Prepares Canadian Long-Term Care Facilities to Enroll Participants in a Clinical Trial Evaluating Favipiravir as an Ou...

Site screening is required in advance of potential outbreaks in Ontario long-term care centers Only trial in the world investigating use of favipiravir as preventative measure against COVID-19...

Appili Therapeutics Announces FY 2020 Annual and Financial Results

Company well-capitalized, reporting record level of capital support with over $27M CAN in equity financings Pipeline portfolio strengthened with initiation of unique COVID-19 clinical study...

Appili Therapeutics Commences Trading on the OTCQX Marketplace

Appili Therapeutics Inc. (TSXV: APLI; OTCQX: APLIF) (the “Company” or “Appili”) is pleased to announce today that its common shares began trading on the OTCQX Best Market®. The OTCQX Market...

L'OCRCVM permet la reprise de la négociation - APLI

L'OCRCVM permet la reprise de la négociation - APLI Canada NewsWire VANCOUVER, BC, le 4 juin 2020 VANCOUVER, BC, le 4 juin 2020 /CNW/ - Reprise des négociations pour : Société : Appili...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NCNCnoco noco Inc
$ 0.28
(83.01%)
299.33M
WINTWindtree Therapeutics Inc
$ 9.19
(61.80%)
682.87k
NUZENuZee Inc
$ 5.915
(59.86%)
36.61M
PMECPrimech Holdings Ltd
$ 0.8299
(57.72%)
99.13M
LSHLakeside Holding Ltd
$ 3.70
(56.12%)
28.51M
CETUUCetus Capital Acquisition Corporation
$ 2.60
(-62.86%)
3.1k
CETUCetus Capital Acquisition Corporation
$ 2.22
(-62.18%)
537.72k
IMNNImunon Inc
$ 1.33
(-59.94%)
16.24M
FGENFibroGen Inc
$ 0.5417
(-47.41%)
16.48M
VCNXVaccinex Inc
$ 5.09
(-36.85%)
1.06M
NVDANVIDIA Corporation
$ 117.02
(12.81%)
473.3M
NCNCnoco noco Inc
$ 0.28
(83.01%)
299.33M
SQQQProShares UltraPro Short QQQ
$ 8.59
(-8.91%)
244.35M
PRSTPresto Technologies Inc
$ 0.038406
(9.73%)
207.14M
FFIEFaraday Future Intelligent Electric Inc
$ 0.343
(8.54%)
145.24M

Discussion

View Full Feed
236T568 236T568 5 minutes ago
MoronMan is speechless

https://x.com/sahilkapur/status/1818849276266475833?s=19
Omegaguy567 Omegaguy567 7 minutes ago
I don’t always respond to the stupidity but sometimes it’s entertaining

That's like 99% of your posts and I agree it's entertaining. Thank you for your service.
ELTP
Noghawbuck Noghawbuck 7 minutes ago
Maybe he’s a sociopathic liar we may need to have him get medical examination?
FUNN
TJ24 TJ24 7 minutes ago
Hello, docsetc.

In your most recent response to me, you said that you and your brother, a lawyer, wanted to see the agreement that I had signed to invest into BioClonetics.

Well, the agreement appears at the following link:
https://www.sec.gov/Archives/edgar/data
ENZC
One11 One11 9 minutes ago
Wait, are you submitting a resume?
How come your mom hasn't locked your tablet? Time for beddy bye, wittle shoo shoo..
MGON
Ayock Ayock 10 minutes ago
Safe?

https://scontent-sea1-1.xx.fbcdn.net/v/t39.30808-6/453207456_906201561549224_1971378753254258061_n.jpg?_nc_cat=105&ccb=1-7&_nc_sid=833d8c&_nc_ohc=Esj_-ZaAJNkQ7kNvgH_Qxh4&_nc_ht=scontent-sea1-1.xx&oh=00_AYBIOud-dkSBiMwB6F1e-ESSTZzp2AAbXMHejaggRr_PhA&oe=66B0D77E

htt
Batman412 Batman412 11 minutes ago
Let’s just say one day it will all come together
TONR
janice shell janice shell 11 minutes ago
For one the sugar is a killer. No wonder obesity is a problem.

The rest of the ingredients, and the way they're combined, would kill you MUCH faster.
Acme Investments Acme Investments 11 minutes ago
Market is overbought!! Just keeping options unpredictable!! Will head back towards 100!!
MU
Ron Burgandy79 Ron Burgandy79 12 minutes ago
Wasn’t watching today but wow, dropped all the way down to .0019. What a lack of confidence in Linda and Reggie. They sure can’t seem to do anything right. I still love the idea of them hosting a shareholders meeting where we can ask them anything we want. My goodness they must be humiliated at how
DBMM
ramfan60 ramfan60 12 minutes ago
Capt'n Independent Study is back......when are you going to give this up Kiwi? Do you realize the reason the EU gave AMRN exclusivity until 2039 was because of the Reduce-It study results? The reason certain countries are dragging their feet on reimbursement is because they can. They'll use whate
AMRN
bar1080 bar1080 13 minutes ago
BTW "New Boeing" will be HQ'd again in Seattle.
Canna_Business Canna_Business 13 minutes ago
The DEA might reclassify cannabis, removing it from the list of schedule-1 drugs. This would enable the FDA to conduct medical research, and allow insurance companies to assist patients by lowering the overall cost of medical cannabis. This could be achieved through a co-pay system similar to what i
MRMD MSOS
mrwrn2010 mrwrn2010 13 minutes ago
Says the one asking for a detailed answer on something he knows is private, yet won’t answer an easy question with the answers clearly posted in the board box.

🤡🤡🤡🤡🤡🤡
ELTP
theorysuit theorysuit 13 minutes ago
people look at share price and assume it is cheap. Look at the market cap (shares outstanding x share price), and this thing certainly ain't cheap sitting at 500M with no cash to their name. Cheap for bio is when your market cap trades below your cash value....that is cheap. This thing has 1.2
NWBO
Canna_Business Canna_Business 13 minutes ago
If the DEA reclassifies cannabis and takes it off the schedule-1 drugs list, the FDA could study it for medical uses. This would also allow insurance companies to help patients reduce the cost of medical cannabis, using a co-pay system like the one for pharmacy prescriptions.

$MSOS $M
MRMD MSOS
CanItBThisEZ2Make CanItBThisEZ2Make 14 minutes ago
BEST SELLERS RANK (BSR) IS 747 21 Estimated Sold on Amazon Since JULY 1 - 3RD Quarter 2024
https://investorshub.advfn.com/uimage/uploads/2024/4/24/cnxttVOS_5G_GIF.gif
https://www.amazon.com/Vos-RDGL5GX55-B-01-VOS-5G-Dongle/dp/B0C66KHZLP

NOTE: In theory, when BSR Value De
SRMX
Canna_Business Canna_Business 14 minutes ago
The potential reclassification of cannabis by the DEA, removing it from the schedule-1 drugs list, could significantly impact both medical research and patient access. By allowing the FDA to thoroughly study cannabis for its medical applications, we could see more evidence-based treatments emerge. A
MRMD MSOS
Hasy1 Hasy1 15 minutes ago
Quality is not a luxury and AIRI is quality. So I buy more shares as nothing is as underpriced as this company. Re creating this company would cost much more than $3.68 per share. The insiders know what the company is worth and they have been buying.
AIRI
RKMKE RKMKE 17 minutes ago
I believe two paid pumpers trying hard to make people believe in a scam???

But am talking based on past facts, results and company communications..

Bloated paper hands pig can’t fly.. i still have that tweet screenshot.
WDLF
bar1080 bar1080 18 minutes ago
How much will Boeing's new CEO make?

"According to a financial filing Wednesday, for the remainder of 2024 from Aug. 8, Ortberg will get a cash payment of $1.25 million in December, plus stock awards valued at $16 million in two sets, one vesting in installments over three years, the
loanshark007 loanshark007 21 minutes ago
I couldn't care less what the sp does. I'm here to call out your bs.
GRST
Fdc4 Fdc4 22 minutes ago
Doesn’t matter. As long as he shows sign of life. I am ok

Let the Ponzi running. We may call it whatever we want but scams also make money. We can get our money back. Let him do what he does best, we will become his cheerleaders if that’s what he wants
VDRM
Fdc4 Fdc4 23 minutes ago
Sold Out Items - Any orders placed will be shipped when inventory is restocked.

Items should be back in stock by August 2024

Waiting for it
VDRM
fngttndn fngttndn 23 minutes ago
Maybe I can buy at .00001
CBIA